Jump Financial’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,142
Closed -$82K 1795
2021
Q4
$82K Buy
+1,142
New +$95.5K 0.01% 1251
2021
Q3
Sell
-1,397
Closed -$135K 1380
2021
Q2
$135K Buy
+1,397
New +$143K 0.01% 946
2021
Q1
Sell
-1,543
Closed -$202K 1182
2020
Q4
$202K Buy
1,543
+193
+14% +$24.9K 0.03% 783
2020
Q3
$143K Buy
+1,350
New +$166K 0.03% 669

Other funds holding NXTC

Jump Financial's NXTC Position: Q1 2022 in Review

Jump Financial sold out of NextCure (NXTC) in Q1 2022, closing a stake of 1,142 shares — an estimated $82K sold.

Jump Financial first reported a position in NXTC in Q3 2020 and held it in 4 quarters. The position peaked at $202K in Q4 2020. 59 funds tracked by Wall St. Rank hold NXTC as of Q1 2022.

  • Jump Financial reported no remaining NextCure position as of Q1 2022 after selling out during the quarter.
  • Jump Financial sold 1,142 NextCure shares in Q1 2022, an estimated $82K.
  • Jump Financial first reported a position in NextCure in Q3 2020 and held it in 4 quarters.
  • Jump Financial's NextCure position peaked at $202K in Q4 2020.
  • 59 funds tracked by Wall St. Rank held NextCure as of Q1 2022.

Based on Jump Financial's 13F filing for Q1 2022, filed 12 May 2022.